Our series notes a much higher cost effectiveness than the one in the study mentioned because we diagnosed 2 lesions in Stage 0 among 650 volunteers 0.3%, 2/ 650. We were able to cure these lesions with ESD with no additional costs since the procedures were included in the program cost, and we obviously avoided the expenses of conventional surgical.
Aunque no se realizó un análisis de costo/efectividad en nuestra serie, se estima una efectividad mucho mayor al estudio mencionado debido al hecho de diagnosticar dos lesiones en estado 0 en 650 voluntarios 0,3%, 2/650, realizar DES curativa sin costo adicional incluida en el costo del programa y obviamente, por evitar los gastos de la cirugía convencional.